CNSP Stock Summary and Trading Ideas (CNS Pharmaceuticals | NASDAQ:CNSP)

CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

CNS Pharmaceuticals trades on the NASDAQ stock market under the symbol CNSP.

As of June 26, 2026, CNSP stock price declined to $3.98 with 15,723 million shares trading.

CNSP has a beta of 3.10, meaning it tends to be more sensitive to market movements. CNSP has a correlation of 0.07 to the broad based SPY ETF.

CNSP has a market cap of $5.82 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, CNSP traded as high as $82,499.99 and as low as $1.90.

The top ETF exchange traded funds that CNSP belongs to (by Net Assets): VXF.

CNSP has underperformed the market in the last year with a price return of -60.4% while the SPY ETF gained +20.4%. However, in the short term, CNSP had mixed performance relative to the market. It has outperformed in the last 3 months, returning +55.5% vs +13.3% return in SPY. But in the last 2 weeks, CNSP shares have been beat by the market, returning -18.6% compared to an SPY return of -1.5%.

CNSP support price is $3.86 and resistance is $4.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CNSP shares will trade within this expected range on the day.